Physician

Michael A Samuel, M.D.

According to 2025 Medicare claims, Michael Samuel, M.D. (NPI: 1730175670) practices ophthalmology in the Riverside-San Bernardino-Ontario, CA market, with the plurality of this provider's patient population coming from Riverside, CA. This provider's primary affiliated billing organization is RETINA INSTITUTE OF CALIFORNIA MEDICAL GROUP, A CALIFORNIA MEDICAL PAR (NPI: 1760541569; TIN: 205944918) and primary practice location at 92260-8700.

Samuel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 944 traditional Medicare patients, billed 13,438 HCPCS/CPT codes, and received $1,576,654 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 1,513 prescription claims across 496 beneficiaries totaling $33,296 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 4 records totaling $467. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,312,922 to $1,576,654. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,004	12,778	$1,312,922
2016	1,176	10,930	$963,263
2017	1,350	11,956	$1,514,077
2018	1,646	18,493	$2,977,425
2019	1,863	20,629	$3,087,814
2020	1,224	14,681	$2,284,846
2021	1,128	15,520	$2,393,110
2022	1,548	18,283	$2,454,433
2023	1,478	22,269	$2,270,315
2024	944	13,438	$1,576,654

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	130	361	$27,082
2016	230	572	$34,671
2017	571	2,323	$132,290
2018	564	2,268	$124,824
2019	457	1,872	$93,083
2020	514	1,694	$76,524
2021	465	1,543	$67,166
2022	563	1,610	$59,101
2023	600	1,777	$66,158
2024	496	1,513	$33,296

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92235	Exam of retinal blood vessels using a special camera after injection of a dye	681	1,213	$121
67028	Injection of drug into eye	222	1,319	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	706	1,234	$70
92134	Imaging of retina	469	1,579	$30
92250	Photography of the retina	679	1,206	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	281	6,582	$7,838
Latanoprost	Latanoprost	514	26,167	$5,166
Brimonidine Tartrate	Brimonidine Tartrate	118	4,636	$2,885
Ofloxacin	Ofloxacin	219	3,819	$2,107
Ketorolac Tromethamine	Ketorolac Tromethamine	104	3,023	$1,767

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$467	Bausch & Lomb Americas Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael A. Samuel, M.D.?

Tedicare shows public-source Medicare data for Michael A. Samuel, M.D. (NPI 1730175670), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael A. Samuel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael A. Samuel, M.D.?

Michael A. Samuel, M.D. is linked to RETINA INSTITUTE OF CALIFORNIA MEDICAL GROUP, A CALIFORNIA MEDICAL PAR (billing NPI 1760541569) in the available physician profile data.

Does Michael A. Samuel, M.D. have Open Payments data?

Michael A. Samuel, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.